Patents by Inventor Bradley J. Martin

Bradley J. Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9084929
    Abstract: A children's building block crashing game and a method of conducting the building block crashing game in which building block assembly structures are crashed upon collision. Players assemble personally designed or preconfigured building block sets which meet the game restrictions on size and thickness, and then crash them together by sliding the structures down a low friction mat through a protective plastic shield. The player with the last piece remaining in the tunnel wins the round.
    Type: Grant
    Filed: August 4, 2014
    Date of Patent: July 21, 2015
    Inventor: Bradley J. Martin
  • Publication number: 20150050860
    Abstract: A children's building block crashing game and a method of conducting the building block crashing game in which building block assembly structures are crashed upon collision. Players assemble personally designed or preconfigured building block sets which meet the game restrictions on size and thickness, and then crash them together by sliding the structures down a low friction mat through a protective plastic shield. The player with the last piece remaining in the tunnel wins the round.
    Type: Application
    Filed: August 4, 2014
    Publication date: February 19, 2015
    Inventor: BRADLEY J. MARTIN
  • Patent number: 8852570
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectable or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Grant
    Filed: February 9, 2012
    Date of Patent: October 7, 2014
    Assignee: Mesoblast International Sarl
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Patent number: 8852571
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Grant
    Filed: February 9, 2012
    Date of Patent: October 7, 2014
    Assignee: Mesoblast International Sarl
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Patent number: 8761356
    Abstract: A method for screening and routing incoming telephone calls includes extracting caller identification information from an incoming telephone call, providing a plurality of tables including a primary ring table, a secondary ring table, a voicemail table, a block call table, and a forward call table, and determining which one of the plurality of tables includes the caller identification information. The method further includes sending the incoming telephone call directly to voicemail without having a ring tone if the voicemail table includes the caller identification information, blocking the incoming telephone call if the block call table includes the caller identification information, and forwarding the incoming telephone call if the forward call table includes the caller identification information.
    Type: Grant
    Filed: October 21, 2013
    Date of Patent: June 24, 2014
    Inventor: Bradley J. Martin
  • Publication number: 20140051412
    Abstract: A method for screening and routing incoming telephone calls includes extracting caller identification information from an incoming telephone call, providing a plurality of tables including a primary ring table, a secondary ring table, a voicemail table, a block call table, and a forward call table, and determining which one of the plurality of tables includes the caller identification information. The method further includes sending the incoming telephone call directly to voicemail without having a ring tone if the voicemail table includes the caller identification information, blocking the incoming telephone call if the block call table includes the caller identification information, and forwarding the incoming telephone call if the forward call table includes the caller identification information.
    Type: Application
    Filed: October 21, 2013
    Publication date: February 20, 2014
    Inventor: Bradley J. Martin
  • Patent number: 8565403
    Abstract: A method for screening and routing incoming telephone calls includes extracting caller identification information from an incoming telephone call, providing a plurality of tables including a primary ring table, a secondary ring table, a voicemail table, a block call table, and a forward call table, and determining which one of the plurality of tables includes the caller identification information. The method further includes sending the incoming telephone call directly to voicemail without having a ring tone if the voicemail table includes the caller identification information, blocking the incoming telephone call if the block call table includes the caller identification information, and forwarding the incoming telephone call if the forward call table includes the caller identification information.
    Type: Grant
    Filed: December 3, 2012
    Date of Patent: October 22, 2013
    Inventor: Bradley J. Martin
  • Publication number: 20130095798
    Abstract: A method for screening and routing incoming telephone calls includes extracting caller identification information from an incoming telephone call, providing a plurality of tables including a primary ring table, a secondary ring table, a voicemail table, a block call table, and a forward call table, and determining which one of the plurality of tables includes the caller identification information. The method further includes sending the incoming telephone call directly to voicemail without having a ring tone if the voicemail table includes the caller identification information, blocking the incoming telephone call if the block call table includes the caller identification information, and forwarding the incoming telephone call if the forward call table includes the caller identification information.
    Type: Application
    Filed: December 3, 2012
    Publication date: April 18, 2013
    Inventor: Bradley J. Martin
  • Patent number: 8325899
    Abstract: A method for screening and routing incoming telephone calls includes extracting caller identification information from an incoming telephone call, providing a plurality of tables including a primary ring table, a secondary ring table, a voicemail table, a block call table, and a forward call table, and determining which one of the plurality of tables includes the caller identification information. The method further includes sending the incoming telephone call directly to voicemail without having a ring tone if the voicemail table includes the caller identification information, blocking the incoming telephone call if the block call table includes the caller identification information, and forwarding the incoming telephone call if the forward call table includes the caller identification information.
    Type: Grant
    Filed: December 1, 2010
    Date of Patent: December 4, 2012
    Inventor: Bradley J. Martin
  • Publication number: 20120213749
    Abstract: Disclosed is a method for repairing or regenerating blood vessels in the heart of an individual, method of stimulating or promoting angiogenesis in the heart of an individual, or method of stimulating or promoting vascular endothelial growth factor (VEGF) expression in a heart of an individual by administering to the individual an effective amount of mesenchymal stem cells. These cells can be administered as a liquid injectable.
    Type: Application
    Filed: April 24, 2012
    Publication date: August 23, 2012
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Publication number: 20120207716
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Application
    Filed: February 9, 2012
    Publication date: August 16, 2012
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Publication number: 20120141437
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Application
    Filed: February 9, 2012
    Publication date: June 7, 2012
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Patent number: 8158121
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Grant
    Filed: January 25, 2011
    Date of Patent: April 17, 2012
    Assignee: Osiris Therapeutics, Inc.
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Publication number: 20110158965
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Application
    Filed: January 25, 2011
    Publication date: June 30, 2011
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Publication number: 20110158964
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Application
    Filed: January 25, 2011
    Publication date: June 30, 2011
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Publication number: 20110069824
    Abstract: A method for screening and routing incoming telephone calls includes extracting caller identification information from an incoming telephone call, providing a plurality of tables including a primary ring table, a secondary ring table, a voicemail table, a block call table, and a forward call table, and determining which one of the plurality of tables includes the caller identification information. The method further includes sending the incoming telephone call directly to voicemail without having a ring tone if the voicemail table includes the caller identification information, blocking the incoming telephone call if the block call table includes the caller identification information, and forwarding the incoming telephone call if the forward call table includes the caller identification information.
    Type: Application
    Filed: December 1, 2010
    Publication date: March 24, 2011
    Inventor: Bradley J. Martin
  • Patent number: 7892829
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectable or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Grant
    Filed: March 2, 2009
    Date of Patent: February 22, 2011
    Assignee: Osiris Therapeutics, Inc.
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Patent number: 7860230
    Abstract: A method for screening and routing incoming telephone calls includes extracting caller identification information from an incoming telephone call, providing a plurality of tables including a primary ring table, a secondary ring table, a voicemail table, a block call table, and a forward call table, and determining which one of the plurality of tables includes the caller identification information. The method also includes allowing the incoming telephone call to have a primary ring tone if the primary ring table includes the caller identification information, and allowing the incoming telephone call to have a secondary ring tone if the secondary ring table includes the caller identification information.
    Type: Grant
    Filed: December 13, 2004
    Date of Patent: December 28, 2010
    Inventor: Bradley J. Martin
  • Publication number: 20090214493
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectable or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Application
    Filed: March 2, 2009
    Publication date: August 27, 2009
    Applicant: Osiris Therapeutics, Inc.
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Patent number: 7514074
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Grant
    Filed: October 21, 2003
    Date of Patent: April 7, 2009
    Assignee: Osiris Therapeutics, Inc.
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin